Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.72 |
| ▸ | MMP8 | P22894 | 10/20 | 0.72 |
| ▸ | MMP9 | P14780 | 9/20 | 0.72 |
| ▸ | MMP1 | P03956 | 8/20 | 0.72 |
| ▸ | TACR1 | P25103 | 2/20 | 0.70 |
| ▸ | ECE1 | P42892 | 1/20 | 0.61 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.60 |
| ▸ | ADAM12 | O43184 | 1/20 | 0.60 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.60 |
| ▸ | MMP3 | P08254 | 1/20 | 0.60 |
| ▸ | MMP7 | P09237 | 1/20 | 0.60 |
| ▸ | MMP12 | P39900 | 1/20 | 0.60 |
| ▸ | MMP13 | P45452 | 1/20 | 0.60 |
| ▸ | MMP14 | P50281 | 1/20 | 0.60 |
| ▸ | MMP15 | P51511 | 1/20 | 0.60 |
| ▸ | MMP16 | P51512 | 1/20 | 0.60 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.60 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.60 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 0.60 |
| ▸ | MMP17 | Q9ULZ9 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6438893 | 0.90 | TACR1 (0.69) | MMP2MMP8MMP9MMP1TACR1 | |
| SCHEMBL7193888 | 0.90 | TACR1 (0.69) | MMP2MMP8MMP9MMP1TACR1 | |
| SCHEMBL4795667 | 0.86 | MMP2 (0.85) | MMP2MMP8MMP9MMP1ECE1 | |
| SCHEMBL6575025 | 0.86 | MMP2 (0.85) | MMP2MMP8MMP9MMP1ECE1 | |
| SCHEMBL7412775 | 0.85 | MMP2 (0.84) | MMP2MMP8MMP9MMP1ECE1 | |
| SCHEMBL6577793 | 0.84 | MMP2 (1.00) | MMP2MMP8MMP9MMP1ECE1 | |
| SCHEMBL8200364 | 0.84 | TACR1 (0.86) | MMP8MMP9TACR1MMP14CCKBR | |
| SCHEMBL8200367 | 0.84 | TACR1 (0.86) | MMP8MMP9TACR1MMP14CCKBR | |
| SCHEMBL7457278 | 0.83 | MMP1 (0.78) | MMP2MMP8MMP9MMP1MMP7 | |
| SCHEMBL6575485 | 0.82 | MMP1 (0.82) | MMP2MMP8MMP9MMP1ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012112945-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS TO TREAT TUBERCULOSIS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2012-08-23 | — | — | WO | claimed |
| EP-3964242-B1 | SURGICAL STAPLER WITH END EFFECTOR COATING | CILAG GMBH INT (CH) | 2026-02-18 | — | — | EP | disclosed |
| US-11666335-B2 | Surgical stapler with end effector coating | CILAG GMBH INTERNATIONAL (CH) | 2023-06-06 | — | — | US | disclosed |
| CN-111032104-B | Surgical stapler with end effector coating | 爱惜康有限责任公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-110740763-B | Surgical fastener device for preventing degradation of ECM | 爱惜康有限责任公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-110769866-B | Surgical stapler with controlled healing | 爱惜康有限责任公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-110740764-B | Surgical fasteners with broad spectrum MMP inhibitors | 爱惜康有限责任公司 | 2022-05-27 | — | — | CN | disclosed |
| EP-3964242-A1 | SURGICAL STAPLER WITH END EFFECTOR COATING | Cilag GmbH International (CH) | 2022-03-09 | — | — | EP | disclosed |
| EP-3415179-B1 | SURGICAL FASTENER DEVICE FOR THE PREVENTION OF ECM DEGRADATION | ETHICON LLC (PR) | 2021-12-01 | — | — | EP | disclosed |
| EP-3415176-B1 | SURGICAL STAPLER WITH END EFFECTOR COATING | CILAG GMBH INT (CH) | 2021-09-29 | — | — | EP | disclosed |
| US-20040248813-A1 | Compounds and methods for the modulation of cd154 | CBR INSTITUTE FOR BIOMEDICAL RESEARCH, INC. | 2004-12-09 | — | — | US | disclosed |
| WO-2004105837-A2 | COMPOUNDS AND METHODS FOR IMPROVING PLATELET RECOVERY AND FUNCTION | CENTER FOR BLOOD RESEARCH, INC. (US) | 2004-12-09 | — | — | WO | disclosed |
| US-20040235950-A1 | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes | REGENTS OF THE UNIVERSITY OF MICHIGAN, THE | 2004-11-25 | — | — | US | disclosed |
| US-20040072750-A1 | Compounds and methods for the modulation of CD154 | MILLENNIUM PHARMACEUTICALS, INC. | 2004-04-15 | — | — | US | disclosed |
| EP-1399466-A2 | COMPOUNDS AND METHODS FOR THE MODULATION OF CD154 | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2004-03-24 | — | — | EP | disclosed |
| US-20040048803-A1 | Compounds and methods for the modulation of CD154 | PHILLIPS DAVID (US) | 2004-03-11 | — | — | US | disclosed |
| EP-1284721-A2 | COMPOSITIONS AND METHODS FOR USE AGAINST ACNE-INDUCED INFLAMMATION AND DERMAL MATRIX-DEGRADING ENZYMES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2003-02-26 | — | — | EP | disclosed |
| WO-2002089730-A2 | COMPOUNDS AND METHODS FOR THE MODULATION OF CD154 | THE CENTER FOR BLOOD RESEARCH, INC. (US) | 2002-11-14 | — | — | WO | disclosed |
| US-20020165166-A1 | Compounds and methods for the modulation of CD154 | CBR INSTITUTE FOR BIOMEDICAL RESEARCH, INC. | 2002-11-07 | — | — | US | disclosed |
| WO-2001089502-A2 | COMPOSITIONS AND METHODS FOR USE AGAINST ACNE-INDUCED INFLAMMATION AND DERMAL MATRIX-DEGRADING ENZYMES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2001-11-29 | — | — | WO | disclosed |